Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Adele De Ninno is active.

Publication


Featured researches published by Adele De Ninno.


Science | 2015

Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1

Erika Vacchelli; Yuting Ma; Elisa E. Baracco; Antonella Sistigu; David Enot; Federico Pietrocola; Heng Yang; Sandy Adjemian; Kariman Chaba; Michaela Semeraro; Michele Signore; Adele De Ninno; Valeria Lucarini; Francesca Peschiaroli; Luca Businaro; Annamaria Gerardino; Gwenola Manic; Thomas Ulas; Patrick Günther; Joachim L. Schultze; Oliver Kepp; Gautier Stoll; Celine Lefebvre; Claire Mulot; Francesca Castoldi; Sylvie Rusakiewicz; Sylvain Ladoire; Lionel Apetoh; José Manuel Bravo-San Pedro; Monica Lucattelli

How dying tumor cells get noticed Besides killing tumor cells directly, some chemotherapies, such as anthracyclines, also activate the immune system to kill tumors. Vacchelli et al. discovered that in mice, anthracycline-induced antitumor immunity requires immune cells to express the protein formyl peptide receptor 1 (FPR1). Dendritic cells (DCs) near tumors expressed especially high amounts of FPR1. DCs normally capture fragments of dying tumor cells and use them to activate nearby T cells to kill tumors, but DCs lacking FPR1 failed to do this effectively. Individuals with breast or colon cancer expressing a variant of FPR1 and treated with anthracyclines showed poor metastasis-free and overall survival. Thus, FPR1 may affect anti-tumor immunity in people, too. Science, this issue p. 972 Formyl peptide receptor 1 helps the immune system sense dying tumor cells. Antitumor immunity driven by intratumoral dendritic cells contributes to the efficacy of anthracycline-based chemotherapy in cancer. We identified a loss-of-function allele of the gene coding for formyl peptide receptor 1 (FPR1) that was associated with poor metastasis-free and overall survival in breast and colorectal cancer patients receiving adjuvant chemotherapy. The therapeutic effects of anthracyclines were abrogated in tumor-bearing Fpr1−/− mice due to impaired antitumor immunity. Fpr1-deficient dendritic cells failed to approach dying cancer cells and, as a result, could not elicit antitumor T cell immunity. Experiments performed in a microfluidic device confirmed that FPR1 and its ligand, annexin-1, promoted stable interactions between dying cancer cells and human or murine leukocytes. Altogether, these results highlight the importance of FPR1 in chemotherapy-induced anticancer immune responses.


Journal of Immunotoxicology | 2014

A multidisciplinary study using in vivo tumor models and microfluidic cell-on-chip approach to explore the cross-talk between cancer and immune cells

Fabrizio Mattei; Giovanna Schiavoni; Adele De Ninno; Valeria Lucarini; Paola Sestili; Antonella Sistigu; Alessandra Fragale; Massimo Sanchez; Massimo Spada; Annamaria Gerardino; Filippo Belardelli; Luca Businaro; Lucia Gabriele

Abstract A full elucidation of events occurring inside the cancer microenvironment is fundamental for the optimization of more effective therapies. In the present study, the cross-talk between cancer and immune cells was examined by employing mice deficient (KO) in interferon regulatory factor (IRF)-8, a transcription factor essential for induction of competent immune responses. The in vivo results showed that IRF-8 KO mice were highly permissive to B16.F10 melanoma growth and metastasis due to failure of their immune cells to exert proper immunosurveillance. These events were found to be dependent on soluble factors released by cells of the immune system capable of shaping the malignant phenotype of melanoma cells. An on-chip model was then generated to further explore the reciprocal interactions between the B16.F10 and immune cells. B16.F10 and immune cells were co-cultured in a microfluidic device composed of three culturing chambers suitably inter-connected by an array of microchannels; mutual interactions were then followed using time-lapse microscopy. It was observed that WT immune cells migrated through the microchannels towards the B16.F10 cells, establishing tight interactions that in turn limited tumor spread. In contrast, IRF-8 KO immune cells poorly interacted with the melanoma cells, resulting in a more invasive behavior of the B16.F10 cells. These results suggest that IRF-8 expression plays a key role in the cross-talk between melanoma and immune cells, and under-score the value of cell-on-chip approaches as useful in vitro tools to reconstruct complex in vivo microenvironments on a microscale level to explore cell interactions such as those occurring within a cancer immunoenvironment.


Scientific Reports | 2015

Cancer-driven dynamics of immune cells in a microfluidic environment

Elena Agliari; Elena Biselli; Adele De Ninno; Giovanna Schiavoni; Lucia Gabriele; Anna Gerardino; Fabrizio Mattei; Adriano Barra; Luca Businaro

Scope of the present work is to infer the migratory ability of leukocytes by stochastic processes in order to distinguish the spontaneous organization of immune cells against an insult (namely cancer). For this purpose, spleen cells from immunodeficient mice, selectively lacking the transcription factor IRF-8 (IRF-8 knockout; IRF-8 KO), or from immunocompetent animals (wild-type; WT), were allowed to interact, alternatively, with murine B16.F10 melanoma cells in an ad hoc microfluidic environment developed on a LabOnChip technology. In this setting, only WT spleen cells were able to establish physical interactions with melanoma cells. Conversely, IRF-8 KO immune cells exhibited poor dynamical reactivity towards the neoplastic cells. In the present study, we collected data on the motility of these two types of spleen cells and built a complete set of observables that recapitulate the biological complexity of the system in these experiments. With remarkable accuracy, we concluded that the IRF-8 KO cells performed pure uncorrelated random walks, while WT splenocytes were able to make singular drifted random walks that collapsed on a straight ballistic motion for the system as a whole, hence giving rise to a highly coordinate response. These results may provide a useful system to quantitatively analyse the real time cell-cell interactions and to foresee the behavior of immune cells with tumor cells at the tissue level.


eLife | 2016

Acetylated tubulin is essential for touch sensation in mice.

Shane J Morley; Yanmei Qi; Loredana Iovino; Laura Andolfi; Da Guo; Nereo Kalebic; Laura Castaldi; Christian Tischer; Carla Portulano; Giulia Bolasco; Kalyanee Shirlekar; Claudia M Fusco; Antonino Asaro; Federica Fermani; Mayya Sundukova; Ulf Matti; Luc Reymond; Adele De Ninno; Luca Businaro; Kai Johnsson; Marco Lazzarino; Jonas Ries; Yannick Schwab; Jing Hu; Paul A. Heppenstall

At its most fundamental level, touch sensation requires the translation of mechanical energy into mechanosensitive ion channel opening, thereby generating electro-chemical signals. Our understanding of this process, especially how the cytoskeleton influences it, remains unknown. Here we demonstrate that mice lacking the α-tubulin acetyltransferase Atat1 in sensory neurons display profound deficits in their ability to detect mechanical stimuli. We show that all cutaneous afferent subtypes, including nociceptors have strongly reduced mechanosensitivity upon Atat1 deletion, and that consequently, mice are largely insensitive to mechanical touch and pain. We establish that this broad loss of mechanosensitivity is dependent upon the acetyltransferase activity of Atat1, which when absent leads to a decrease in cellular elasticity. By mimicking α-tubulin acetylation genetically, we show both cellular rigidity and mechanosensitivity can be restored in Atat1 deficient sensory neurons. Hence, our results indicate that by influencing cellular stiffness, α-tubulin acetylation sets the force required for touch. DOI: http://dx.doi.org/10.7554/eLife.20813.001


Scientific Reports | 2017

3D Microfluidic model for evaluating immunotherapy efficacy by tracking dendritic cell behaviour toward tumor cells

Stefania Parlato; Adele De Ninno; Rosa Molfetta; Elena Toschi; Debora Salerno; Arianna Mencattini; Giulia Romagnoli; Alessandra Fragale; Lorenzo Roccazzello; Maria Buoncervello; Irene Canini; Enrico Bentivegna; Mario Falchi; Francesca Romana Bertani; Annamaria Gerardino; Eugenio Martinelli; Corrado Di Natale; Rossella Paolini; Luca Businaro; Lucia Gabriele

Immunotherapy efficacy relies on the crosstalk within the tumor microenvironment between cancer and dendritic cells (DCs) resulting in the induction of a potent and effective antitumor response. DCs have the specific role of recognizing cancer cells, taking up tumor antigens (Ags) and then migrating to lymph nodes for Ag (cross)-presentation to naïve T cells. Interferon-α-conditioned DCs (IFN-DCs) exhibit marked phagocytic activity and the special ability of inducing Ag-specific T-cell response. Here, we have developed a novel microfluidic platform recreating tightly interconnected cancer and immune systems with specific 3D environmental properties, for tracking human DC behaviour toward tumor cells. By combining our microfluidic platform with advanced microscopy and a revised cell tracking analysis algorithm, it was possible to evaluate the guided efficient motion of IFN-DCs toward drug-treated cancer cells and the succeeding phagocytosis events. Overall, this platform allowed the dissection of IFN-DC-cancer cell interactions within 3D tumor spaces, with the discovery of major underlying factors such as CXCR4 involvement and underscored its potential as an innovative tool to assess the efficacy of immunotherapeutic approaches.


Nano-micro Letters | 2015

Controlling DNA Bundle Size and Spatial Arrangement in Self-assembled Arrays on Superhydrophobic Surface

Gabriele Ciasca; Massimiliano Papi; Valentina Palmieri; M. Chiarpotto; Simone Di Claudio; Adele De Ninno; Ennio Giovine; Gaetano Campi; Annamaria Gerardino; Luca Businaro; Marco De Spirito

The use of superhydrophobic surfaces (SHSs) is now emerging as an attractive platform for the realization of one-dimensional (1D) nanostructures with potential applications in many nanotechnological and biotechnological fields. To this purpose, a strict control of the nanostructures size and their spatial arrangement is highly required. However, these parameters may be strongly dependent on the complex evaporation dynamics of the sessile droplet on the SHS. In this work, we investigated the effect of the evaporation dynamics on the size and the spatial arrangement of self-assembled 1D DNA bundles. Our results reveal that different arrangements and bundle size distributions may occur depending on droplet evaporation stage. These results contribute to elucidate the formation mechanism of 1D nanostructures on SHSs.


Scientific Reports | 2017

Computationally Informed Design of a Multi-Axial Actuated Microfluidic Chip Device

Alessio Gizzi; Sara Maria Giannitelli; Marcella Trombetta; C. Cherubini; Simonetta Filippi; Adele De Ninno; Luca Businaro; Annamaria Gerardino; Alberto Rainer

This paper describes the computationally informed design and experimental validation of a microfluidic chip device with multi-axial stretching capabilities. The device, based on PDMS soft-lithography, consisted of a thin porous membrane, mounted between two fluidic compartments, and tensioned via a set of vacuum-driven actuators. A finite element analysis solver implementing a set of different nonlinear elastic and hyperelastic material models was used to drive the design and optimization of chip geometry and to investigate the resulting deformation patterns under multi-axial loading. Computational results were cross-validated by experimental testing of prototypal devices featuring the in silico optimized geometry. The proposed methodology represents a suite of computationally handy simulation tools that might find application in the design and in silico mechanical characterization of a wide range of stretchable microfluidic devices.


Scientific Reports | 2017

Organs on chip approach: A tool to evaluate cancer-immune cells interactions

Elena Biselli; Elena Agliari; Adriano Barra; Francesca Romana Bertani; Annamaria Gerardino; Adele De Ninno; Arianna Mencattini; Davide Di Giuseppe; Fabrizio Mattei; Giovanna Schiavoni; Valeria Lucarini; Erika Vacchelli; Guido Kroemer; Corrado Di Natale; Eugenio Martinelli; Luca Businaro

In this paper we discuss the applicability of numerical descriptors and statistical physics concepts to characterize complex biological systems observed at microscopic level through organ on chip approach. To this end, we employ data collected on a microfluidic platform in which leukocytes can move through suitably built channels toward their target. Leukocyte behavior is recorded by standard time lapse imaging. In particular, we analyze three groups of human peripheral blood mononuclear cells (PBMC): heterozygous mutants (in which only one copy of the FPR1 gene is normal), homozygous mutants (in which both alleles encoding FPR1 are loss-of-function variants) and cells from ‘wild type’ donors (with normal expression of FPR1). We characterize the migration of these cells providing a quantitative confirmation of the essential role of FPR1 in cancer chemotherapy response. Indeed wild type PBMC perform biased random walks toward chemotherapy-treated cancer cells establishing persistent interactions with them. Conversely, heterozygous mutants present a weaker bias in their motion and homozygous mutants perform rather uncorrelated random walks, both failing to engage with their targets. We next focus on wild type cells and study the interactions of leukocytes with cancerous cells developing a novel heuristic procedure, inspired by Lyapunov stability in dynamical systems.


Lab on a Chip | 2013

Cross talk between cancer and immune cells: exploring complex dynamics in a microfluidic environment.

Luca Businaro; Adele De Ninno; Giovanna Schiavoni; Valeria Lucarini; Gabriele Ciasca; Annamaria Gerardino; Filippo Belardelli; Lucia Gabriele; Fabrizio Mattei


Journal of Investigative Dermatology | 2017

Combining Type I Interferons and 5-Aza-2′-Deoxycitidine to Improve Anti-Tumor Response against Melanoma

Valeria Lucarini; Carla Buccione; Giovanna Ziccheddu; Francesca Peschiaroli; Paola Sestili; Rossella Puglisi; Gianfranco Mattia; Cristiana Zanetti; Isabella Parolini; Laura Bracci; Iole Macchia; A. R. Rossi; Maria Teresa D'Urso; Daniele Macchia; Massimo Spada; Adele De Ninno; Annamaria Gerardino; Pamela Mozetic; Marcella Trombetta; Alberto Rainer; Luca Businaro; Giovanna Schiavoni; Fabrizio Mattei

Collaboration


Dive into the Adele De Ninno's collaboration.

Top Co-Authors

Avatar

Luca Businaro

National Research Council

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Fabrizio Mattei

Istituto Superiore di Sanità

View shared research outputs
Top Co-Authors

Avatar

Giovanna Schiavoni

Istituto Superiore di Sanità

View shared research outputs
Top Co-Authors

Avatar

Valeria Lucarini

Istituto Superiore di Sanità

View shared research outputs
Top Co-Authors

Avatar

Lucia Gabriele

Istituto Superiore di Sanità

View shared research outputs
Top Co-Authors

Avatar

Adriano Barra

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Alberto Rainer

Università Campus Bio-Medico

View shared research outputs
Top Co-Authors

Avatar

Alessandra Fragale

Istituto Superiore di Sanità

View shared research outputs
Top Co-Authors

Avatar

Antonella Sistigu

Catholic University of the Sacred Heart

View shared research outputs
Researchain Logo
Decentralizing Knowledge